CLINICAL COMPARISON OFEFFICACY BETWEEN COMBINATIVE THERAPIES IN MANAGEMENT OF SARS-COV-2-INDUCED ARTHRITIS: NSAIDS AND STEROIDS VERSES NSAIDS AND CHONDROPROTECTIVE AGENTS

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that led to the covid-19, results in varying clinical presentations. Long-term complications of SARS-CoV-2 include rheumatologic conditions such as arthritis. Due to the uncertainty surrounding the pathogenesis of SARS-CoV-2-related arthritis, methods of its management vary. This study hypothesized that there would be better outcomes in patients with SARS-CoV-2-related arthritis who were treated with a combination of corticosteroids and nonsteroidal anti-inflammatory drugs (such as ketorolac trometamol and diclofenac) in comparison with patients treated with a combination of nonsteroidal anti-inflammatory medications and chondroprotective drugs (such as glucosamine sulfate, chondroitin sulfate, sodium sulfate).